JP2010536849A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010536849A5 JP2010536849A5 JP2010521817A JP2010521817A JP2010536849A5 JP 2010536849 A5 JP2010536849 A5 JP 2010536849A5 JP 2010521817 A JP2010521817 A JP 2010521817A JP 2010521817 A JP2010521817 A JP 2010521817A JP 2010536849 A5 JP2010536849 A5 JP 2010536849A5
- Authority
- JP
- Japan
- Prior art keywords
- isopropoxyethyl
- thioxo
- pyrrolo
- tetrahydro
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 3
- FVJCUZCRPIMVLB-UHFFFAOYSA-N 1-(2-propan-2-yloxyethyl)-2-sulfanylidene-5h-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound O=C1NC(=S)N(CCOC(C)C)C2=C1NC=C2 FVJCUZCRPIMVLB-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- -1 2-Isopropoxyethyl Chemical group 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000001089 Multiple system atrophy Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95752507P | 2007-08-23 | 2007-08-23 | |
| US95752307P | 2007-08-23 | 2007-08-23 | |
| US60/957,525 | 2007-08-23 | ||
| US60/957,523 | 2007-08-23 | ||
| PCT/SE2008/050950 WO2009025618A1 (en) | 2007-08-23 | 2008-08-22 | Mipo inhibitors for the treatment of huntington's disease and multiple system atrophy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013080125A Division JP2013151547A (ja) | 2007-08-23 | 2013-04-08 | ハンチントン病及び多系統委縮症の処置のためのｍｉｐｏ阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010536849A JP2010536849A (ja) | 2010-12-02 |
| JP2010536849A5 true JP2010536849A5 (https=) | 2012-10-11 |
| JP5247804B2 JP5247804B2 (ja) | 2013-07-24 |
Family
ID=40378392
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010521817A Active JP5247804B2 (ja) | 2007-08-23 | 2008-08-22 | ハンチントン病及び多系統委縮症の処置のためのｍｉｐｏ阻害剤 |
| JP2013080125A Pending JP2013151547A (ja) | 2007-08-23 | 2013-04-08 | ハンチントン病及び多系統委縮症の処置のためのｍｉｐｏ阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013080125A Pending JP2013151547A (ja) | 2007-08-23 | 2013-04-08 | ハンチントン病及び多系統委縮症の処置のためのｍｉｐｏ阻害剤 |
Country Status (25)
| Country | Link |
|---|---|
| US (6) | US20090054468A1 (https=) |
| EP (1) | EP2200616B1 (https=) |
| JP (2) | JP5247804B2 (https=) |
| KR (1) | KR101588464B1 (https=) |
| CN (4) | CN103638029A (https=) |
| AU (1) | AU2008289653B2 (https=) |
| BR (1) | BRPI0815681A2 (https=) |
| CA (1) | CA2698205C (https=) |
| CY (1) | CY1113714T1 (https=) |
| DK (1) | DK2200616T3 (https=) |
| EA (1) | EA017510B1 (https=) |
| ES (1) | ES2399846T3 (https=) |
| HR (1) | HRP20130139T1 (https=) |
| IL (2) | IL203738A (https=) |
| ME (1) | ME01510B (https=) |
| MX (1) | MX2010001983A (https=) |
| MY (1) | MY155633A (https=) |
| NZ (1) | NZ584135A (https=) |
| PH (1) | PH12014501180A1 (https=) |
| PL (1) | PL2200616T3 (https=) |
| PT (1) | PT2200616E (https=) |
| RS (1) | RS52665B (https=) |
| SI (1) | SI2200616T1 (https=) |
| WO (1) | WO2009025618A1 (https=) |
| ZA (1) | ZA201000848B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039385A1 (es) * | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | Derivados de tioxantina como inhibidores de la mieloperoxidasa |
| MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| UY30267A1 (es) * | 2006-04-13 | 2007-11-30 | Astrazeneca Ab | Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones |
| TW200804383A (en) * | 2006-06-05 | 2008-01-16 | Astrazeneca Ab | New compounds |
| US20090054468A1 (en) * | 2007-08-23 | 2009-02-26 | Astrazeneca Ab | New Use 938 |
| EP2627178B1 (en) | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as crth2 antagonists |
| CN103917529B (zh) | 2011-11-11 | 2016-08-17 | 辉瑞大药厂 | 2-硫代嘧啶酮类 |
| JP2015512905A (ja) * | 2012-03-29 | 2015-04-30 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 有害動物を駆除するためのｎ−置換複素二環式化合物および誘導体ｉｉ |
| US9616063B2 (en) * | 2014-12-01 | 2017-04-11 | Astrazeneca Ab | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase |
| AU2016257179A1 (en) | 2015-05-05 | 2017-11-02 | Pfizer Inc. | 2-thiopyrimidinones |
| US11382918B2 (en) * | 2017-06-28 | 2022-07-12 | Ptc Therapeutics, Inc. | Methods for treating Huntington's Disease |
| AU2018304508B2 (en) * | 2017-07-17 | 2021-06-10 | Astrazeneca Ab | MPO inhibitors for use in medicine |
| CA3157260A1 (en) * | 2019-10-10 | 2021-04-15 | Biohaven Therapeutics Ltd. | Prodrugs of myeloperoxidase inhibitors |
| WO2021178734A1 (en) * | 2020-03-05 | 2021-09-10 | Biohaven Therapeutics Ltd. | Method of treating amyotrophic lateral sclerosis with myeloperoxidase inhibitor |
| CA3181917A1 (en) * | 2020-05-06 | 2021-11-11 | Biohaven Therapeutics Ltd. | Process for the preparation of verdiperstat |
| CN115403584B (zh) * | 2021-05-26 | 2024-04-02 | 长春金赛药业有限责任公司 | 2-硫代-2,3-二氢嘧啶-4-酮衍生物、药物组合物及其制备方法和应用 |
| CN119894896A (zh) | 2022-08-18 | 2025-04-25 | 阿斯利康(瑞典)有限公司 | 绿过氧化物酶的抑制剂 |
| EP4580606A1 (en) * | 2022-08-31 | 2025-07-09 | Astrazeneca AB | Pharmaceutical formulation |
| CN120265633A (zh) * | 2022-12-09 | 2025-07-04 | 深圳信立泰药业股份有限公司 | 一种吡咯并[3,2-d]嘧啶-4-酮类衍生物及其制备方法和医药用途 |
| WO2024163892A1 (en) * | 2023-02-02 | 2024-08-08 | University Of Virginia Patent Foundation | Myeloperoxidase (mpo) inhibition as a treatment target for delayed cerebral injury (dci) in aneurysmal subarachnoid hemorrhage (sah) |
| WO2025172474A1 (en) | 2024-02-15 | 2025-08-21 | Astrazeneca Ab | Inhibitors of myeloperoxidase |
| WO2025190901A1 (en) | 2024-03-13 | 2025-09-18 | Institut National de la Santé et de la Recherche Médicale | Use of myeloperoxidase (mpo) inhibitors for promoting cd8+ t cell responses |
| CN121378265A (zh) * | 2025-10-30 | 2026-01-23 | 乐平市康鑫医药化工有限公司 | 一种吡唑类化合物及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69834500T2 (de) * | 1997-09-05 | 2007-05-03 | Kyowa Hakko Kogyo Co., Ltd. | Xanthinderivative zur behandlung von hirnischämie |
| GB0100623D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds IV |
| GB0100620D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical cokpounds V |
| KR101098209B1 (ko) * | 2002-01-28 | 2011-12-23 | 교와 핫꼬 기린 가부시키가이샤 | 운동성 질환에 걸린 환자의 치료 방법 |
| AR039385A1 (es) * | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | Derivados de tioxantina como inhibidores de la mieloperoxidasa |
| SE0302756D0 (sv) * | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel Compounds |
| MY140748A (en) * | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| UY30267A1 (es) * | 2006-04-13 | 2007-11-30 | Astrazeneca Ab | Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones |
| CN101460501A (zh) * | 2006-06-05 | 2009-06-17 | 阿斯利康(瑞典)有限公司 | 作为髓过氧化物酶抑制剂的吡咯并[3，2-d]嘧啶-4-酮衍生物 |
| AR066936A1 (es) * | 2007-06-13 | 2009-09-23 | Astrazeneca Ab | 3 - (2r - tetrahidrofuril - metil) - 2 - tioxantina. composiciones farmaceuticas. |
| US20090054468A1 (en) * | 2007-08-23 | 2009-02-26 | Astrazeneca Ab | New Use 938 |
-
2008
- 2008-08-21 US US12/195,527 patent/US20090054468A1/en not_active Abandoned
- 2008-08-22 WO PCT/SE2008/050950 patent/WO2009025618A1/en not_active Ceased
- 2008-08-22 BR BRPI0815681-6A2A patent/BRPI0815681A2/pt not_active IP Right Cessation
- 2008-08-22 EA EA201000202A patent/EA017510B1/ru not_active IP Right Cessation
- 2008-08-22 RS RS20130070A patent/RS52665B/sr unknown
- 2008-08-22 PL PL08794174T patent/PL2200616T3/pl unknown
- 2008-08-22 ME MEP-2013-49A patent/ME01510B/me unknown
- 2008-08-22 HR HRP20130139AT patent/HRP20130139T1/hr unknown
- 2008-08-22 JP JP2010521817A patent/JP5247804B2/ja active Active
- 2008-08-22 SI SI200830893T patent/SI2200616T1/sl unknown
- 2008-08-22 NZ NZ584135A patent/NZ584135A/en not_active IP Right Cessation
- 2008-08-22 CN CN201310681047.4A patent/CN103638029A/zh active Pending
- 2008-08-22 CN CN202110874748.4A patent/CN113633641A/zh active Pending
- 2008-08-22 EP EP08794174A patent/EP2200616B1/en active Active
- 2008-08-22 PT PT87941746T patent/PT2200616E/pt unknown
- 2008-08-22 ES ES08794174T patent/ES2399846T3/es active Active
- 2008-08-22 CN CN201610055826.7A patent/CN105687199A/zh active Pending
- 2008-08-22 MY MYPI2010000753A patent/MY155633A/en unknown
- 2008-08-22 DK DK08794174.6T patent/DK2200616T3/da active
- 2008-08-22 CA CA2698205A patent/CA2698205C/en not_active Expired - Fee Related
- 2008-08-22 KR KR1020107003835A patent/KR101588464B1/ko not_active Expired - Fee Related
- 2008-08-22 CN CN200880111701A patent/CN101873857A/zh active Pending
- 2008-08-22 AU AU2008289653A patent/AU2008289653B2/en not_active Ceased
- 2008-08-22 MX MX2010001983A patent/MX2010001983A/es active IP Right Grant
-
2010
- 2010-02-04 IL IL203738A patent/IL203738A/en not_active IP Right Cessation
- 2010-02-04 ZA ZA2010/00848A patent/ZA201000848B/en unknown
-
2011
- 2011-02-23 US US13/033,220 patent/US20110207755A1/en not_active Abandoned
-
2012
- 2012-11-01 US US13/666,504 patent/US20130059870A1/en not_active Abandoned
-
2013
- 2013-02-21 CY CY20131100166T patent/CY1113714T1/el unknown
- 2013-04-08 JP JP2013080125A patent/JP2013151547A/ja active Pending
- 2013-11-08 US US14/075,790 patent/US20140221400A1/en not_active Abandoned
-
2014
- 2014-05-26 PH PH12014501180A patent/PH12014501180A1/en unknown
-
2015
- 2015-07-23 IL IL240130A patent/IL240130A0/en unknown
-
2018
- 2018-08-30 US US16/117,020 patent/US10772890B2/en active Active
-
2020
- 2020-09-13 US US17/019,276 patent/US20200405724A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010536849A5 (https=) | ||
| IL203738A (en) | Use of 1- (2-Isopropoxyethyl) -2-Theoxo-1, 2, 3, 5-Tetrahydro-Pyrolo [3, 2-d] Pyrimidine-4-On or its Acceptable Pharmaceutical Salt for the Preparation of a Multi-Systemic Degenerative Drug | |
| JP2010529118A5 (https=) | ||
| JP2009537554A5 (https=) | ||
| JP2011522896A5 (https=) | ||
| JP2016539156A5 (https=) | ||
| IL196854A (en) | Indole compounds and their appropriate pharmaceutical salts and their use in the preparation of @ drugs | |
| IL217901B (en) | Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| HRP20180942T1 (hr) | Liječenje negativnih simptoma shizofrenije s (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamidom i njegovim farmaceutski prihvatljivim solima | |
| JP2015515475A5 (https=) | ||
| SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| JP2012532874A5 (https=) | ||
| NZ714963A (en) | Compositions and methods for treating anemia | |
| FI3628319T3 (fi) | Hepaattisen enkefalopatian hoito rifaksimiinilla | |
| PH12013500172A1 (en) | Use of binders for manufacturing storage stable formulations | |
| HRP20180237T4 (hr) | Metode za liječenje hcv-a | |
| JP2010535814A5 (https=) | ||
| JP2011522816A5 (https=) | ||
| JP2012512158A5 (https=) | ||
| ZA201007391B (en) | Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood | |
| JP2009518415A5 (https=) | ||
| WO2007145863A3 (en) | Sustained release formulation of naltrexone | |
| DK2802319T3 (da) | Fastdosiskombinationsterapi for parkinsons sygdom | |
| FI3919060T3 (fi) | Ecopipam touretten oireyhtymän hoitoon |